Pharma Foods International (2929) · FactRe-recognition of gain on sale of investment securities
Planned Recognition of Extraordinary Income from the Sale of Investment Securities
First written in FY2017-Q3. 1 of 3 entries say "Achieved", first in FY2018-Q3. Latest entry: FY2024-Q3.
3entries
8years
0from disclosures
How it moved
Same theme, other companies
Recognition of gain on sale of investment securities and shares in affiliatesA theme 314 companies write about · 1 as a headwind · 336 as a tailwind
84 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 182 companies compared. The sentences above are computed from all 182.Comparing 200 of the theme's 340 threads.Full recordFilings, disclosures and news, newest first
- FY2024-Q3Re-recognition of gain on sale of investment securitiesAnnual report
「Gain on sale of investment securities 10」
A gain on the sale of investment securities of ¥10 million was recognized as extraordinary income during the cumulative third quarter. - FY2018-Q3AchievedAnnual report
「Gain on sale of investment securities 19,737」
The previously scheduled gain on the sale of investment securities was actually recognized as extraordinary income at ¥19.737 million. - FY2017-Q3First statedAnnual report
「In May 2017, the company sold part of its investment securities, consisting of one listed stock. Accordingly, it plans to recognize a gain on the sale of investment securities of ¥21.190 million as extraordinary income in the fourth quarter of the fiscal year ending July 2017.」
The company disclosed that, in May 2017 after the filing, it sold part of one listed stock and planned to recognize a gain on the sale of ¥21.190 million in the fourth quarter.